‘Disconnect’ between PBS listings, guidelines

PBAC and experts debate PBS restrictions following its rejection for listing of new therapy The PBAC and other experts have investigated "several disconnections" in currently available medicines for pulmonary arterial hypertension (PAH) on the PBS and international guidelines for treatment of the condition. In response to its March decision not to recommend PBS listing of